Topical vs injectable GHK-Cu: what the evidence shows

The short answer: topical GHK-Cu is the form with human evidence, and injectable GHK-Cu is the form without it. Copper peptide creams and serums have small controlled cosmetic studies on aging skin and are lawfully sold as cosmetics. [1] [7] Injectable GHK-Cu has no published human trial for any condition, and it has no lawful compounding path in the United States today. [8]

This post compares the two forms on evidence, absorption, safety, and legality. It does not give injection doses or instructions.

What is GHK-Cu?

GHK-Cu is glycyl-histidyl-lysine bound to copper. GHK occurs naturally in human plasma, and its levels fall with age. [2] In cell and animal studies it attracts repair cells to injuries, increases collagen and elastin production, and dampens inflammatory signals. [2] [3] It appears on cosmetic labels as copper tripeptide-1.

What does the topical GHK-Cu evidence show?

Topical GHK-Cu has the only human data, and it is thin:

• Cosmetic studies on aging skin. Reviews describe controlled studies in which copper peptide creams tightened loose skin, improved elasticity and density, and reduced fine lines and photodamage over about 8 to 12 weeks. [1] Most were small and industry associated, and they are reported through reviews written largely by the peptide's discoverer rather than as large independent trials. [1]
• An independent review of topical peptides grouped GHK-Cu with the "carrier peptides" that deliver trace elements to skin and reviewed the controlled studies for signs of aging. [4]
• A small randomized study after laser resurfacing found no objective difference in redness, wrinkles, or overall skin quality between copper peptide skin care and a regimen without it, though patients using the copper peptide products were more satisfied. [5]

Put together: topical GHK-Cu has plausible biology and some encouraging small studies, one independent randomized study that found no objective effect, and no large trial. Our dataset grades it human observational for skin aging.

Does topical GHK-Cu get through the skin?

This is the main argument made for injecting it: that a cream cannot reach the living layers of skin. The lab evidence says some of it can. In diffusion cells using human skin, copper from a 0.68% GHK-Cu solution permeated dermatomed skin over 48 hours, and a portion was retained in the skin as a depot. [6]

That is a lab measurement of copper movement, not proof of a clinical effect, but it undercuts the idea that injection is the only way GHK-Cu reaches skin cells.

What does the injectable GHK-Cu evidence show?

For people, nothing. No indexed human trial of injected GHK-Cu has been published for skin, wound healing, hair, or recovery. [3] Injected or systemic GHK-Cu has been studied in animals: reviews report that it induced systemic wound healing in rats, mice, and pigs. [1] Those animal studies did not establish a human dose, and no human dose finding study exists.

So when an injectable is marketed with skin results, the human evidence being borrowed comes from creams. The wound healing page covers what does have human evidence for repair.

Topical vs injectable GHK-Cu, side by side

• Human evidence: topical has small controlled cosmetic studies; injectable has none. [1]
• Absorption: topical penetrates human skin in lab studies; injectable bypasses the skin barrier but has no human pharmacokinetic data. [6]
• Safety data: topical was generally well tolerated with occasional irritation; injectable has no systematic human safety data. [1]
• Legal status: topical is a lawful cosmetic; injectable has no lawful compounding path. [7] [8]
• Anti-doping: topical is not a concern; injectable should be treated as prohibited under WADA section S0. [10]

Why is injectable GHK-Cu marketed if the evidence is topical?

Mostly because of the animal data and the mechanism. Reviews describe systemic wound healing in rats, mice, and pigs after GHK-Cu was given away from the wound, and gene expression studies suggesting it shifts many repair and inflammation genes. [1] [3] Those findings make a whole-body effect plausible, and marketing turns plausible into promised.

What is missing is the step in between: a human study that gives injected GHK-Cu to people and measures skin, healing, or safety against a placebo. Until that exists, an injection is an experiment with an unknown dose and unknown risks, and a cream is the only form tested on human skin.

What would settle the question?

A fair comparison would randomize people to a GHK-Cu cream, an injected form, and a placebo, and measure the same outcomes in all three: wrinkle depth, elasticity, and side effects, rated by evaluators who do not know who got what. No such trial has been registered or published. The one independent randomized study of a copper peptide product used blinded evaluators and found no objective difference, which is the kind of result marketing rarely mentions. [5]

Is injectable GHK-Cu safe?

No one knows. There are no systematic human safety data for the injected form. Reviews report both pro-repair activity and anti-cancer activity in cell studies, so the effect of a growth-promoting peptide on an existing tumor is unresolved. [3] Repeated large injected doses also raise a theoretical copper overload concern that has not been studied in people. Products labeled for research use are not checked for identity, purity, or sterility by any regulator.

Is GHK-Cu legal?

It depends on the form:

• Topical: a cosmetic that claims only to change appearance does not need FDA premarket approval. If it claims to treat or prevent disease, it becomes a drug. [7]
• Injectable: GHK-Cu was nominated for the 503A bulks list and placed in Category 2. FDA's page current as of April 22, 2026 now lists it among nominations that were withdrawn, so it is off Category 2 but not on the bulks list. [9] Without a bulks listing, a 503A pharmacy has no federal basis to compound it from bulk, and it was not reviewed at the July 2026 advisory committee meeting. [8]

Follow changes on the GHK-Cu regulatory page, see GHK-Cu cost for why there is no lawful compounded price, and check state rules on our state law pages.

If a clinic offers injections, how to get peptides prescribed explains what a lawful prescription requires, and what is peptide therapy explains how the term is used.

What about GHK-Cu in blends?

Injectable GHK-Cu is the ingredient that gives the Glow and Klow blends their skin marketing, and it is also the reason neither blend has a lawful path. We compare them in Klow vs Glow. For single-peptide comparisons, see BPC-157 vs GHK-Cu and TB-500 vs GHK-Cu.

Does GHK-Cu help hair?

Copper peptides are common in hair serums, but no randomized human trial of GHK-Cu alone for hair loss has been published. [2] We cover the follicle studies and how they compare with approved treatments in copper peptides for hair and on the hair loss page.

The takeaway

If you are choosing between forms, the evidence points one way: topical GHK-Cu has small human skin studies, lab evidence that it penetrates skin, and a lawful market. Injectable GHK-Cu has animal data, no human trial, no safety data, and no lawful compounding path. We will update this page if a human trial of either form is published or FDA changes its status.